Company profile: Sanovel
1.1 - Company Overview
Company description
- Provider of pharmaceutical products, manufacturing anti-inflammatory, anti-asthmatic, and antibacterial medications.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sanovel
Phasex
HQ: United States
Website
- Description: Provider of supercritical CO2 extraction for natural products, primarily serving the natural products, biopharmaceuticals, and polymers market segments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phasex company profile →
Alpex
HQ: Switzerland
Website
- Description: Provider of research and development and production of orally dispersible tablets (ODT), also known as fast melt, and effervescent tablets. Offers a unique proprietary covering ODT technology, supported by high production capacity and advanced R&D technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alpex company profile →
Althea Technologies
HQ: United States
Website
- Description: Provider of contract manufacturing services to the pharmaceutical and biotechnology industries, offering gene expression analysis via eXpress Profiling, quantitative PCR testing, cGMP drug product filling in vials and syringes, and production of microbial-derived recombinant proteins and plasmid DNA.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Althea Technologies company profile →
Surface Ophthalmics
HQ: United States
Website
- Description: Provider of ophthalmic therapeutics leveraging the Klarity delivery vehicle, including SURF-100 topical eyedrops for chronic dry eye (Phase II), SURF-200 for acute dry eye (Phase II), SURF-201 Betamethasone 0.2% solution for post-cataract pain and inflammation (positive Phase II), and an MPA 0.1% chronic dry eye therapy ready for Phase III.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Surface Ophthalmics company profile →
Birgi Mefar
HQ: Turkey
Website
- Description: Provider of contract manufacturing of sterile parenteral solutions and suspensions, filling into ampoules, vials, lyo vials, pre-filled syringes and blow-fill-seal containers; manufacturer of primary packaging producing empty ampoules and vials from clear and amber glass tubing; lab services for stability studies, analytical method and process validation with scale-up; cGMP blistering, labeling, track and trace; GMP cold chain storage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Birgi Mefar company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sanovel
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sanovel
2.2 - Growth funds investing in similar companies to Sanovel
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sanovel
4.2 - Public trading comparable groups for Sanovel
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →